References
- Wang J.J., Cortes E., Sinks L.F., Holland J.F. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer 1971; 28: 837
- Young R.C., Ozols R.F., Myers C.E. The anthracycline antineoplastic drugs. N. Engl. J. Med. 1981; 305: 139
- Rahman A., Kessler A., More N., Sikic B., Rowden G., Woolley P., Schein P.S. Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res. 1980; 40: 1532
- Olson F., Mayhew E., Maslow D., Rustum Y., Szoka F. Characterization, toxicity, and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur. J. Cancer Clin. Oncol., 18: 167
- Gabizon A., Meshorer A., Barenholz Y.J. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J. Natl. Cancer Inst. 1986; 77: 459
- Gregoriadis G. Liposomes as Drug Carriers: Recent Trends and Progress. John Wiley and Sons, New York 1988
- Ostro M.J. Liposomes from Biophysics to Therapeutics. Marcel Dekker, New York 1987
- Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenhal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978; 202: 1290
- Weinstein J.N., Magin R.L., Cysyl R.L., Zaharko D.S. Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate. Cancer Res. 1980; 40: 1388
- Allen T.M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987; 223: 42
- Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268: 235
- Maruyama K., Yuda T., Okamoto A., Ishikura C., Kojima S., Iwatsuru M. Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. Chem. Pharm. Bull. 1991; 39: 1620
- Maruyama K., Unezaki S., Takahashi N., Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta 1993, in press
- Mayer L.D., Bally M.B., Hope M.J., Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to membrane potential. Biochim. Biophys. Acta 1985; 816: 294
- Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989; 49: 5922
- Masuike J., Odake J., Kohagura M., Noda T., Takemoto T. Determination of adriamycin and its metabolites in biological samples using high performance liquid chromatography. II) Analysis of tissues by extraction method. Yakugaku Zasshi (Japanese) 1984; 104: 620
- Iga K., Hamaguchi H., Igari Y., Ogawa Y., Toguchi H., Shimamoto T. Heat-specific drug release of large unilamellar vesicle as hyperthermia-mediated targeting delivery. Int. J. Pharm. 1989; 57: 241
- Magin R.L., Weinstein J.N. “Liposome Technology”, G. Gregoriadis. CRC Press, Boca Raton, FL 1983; Vol. III: 137
- Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation tine in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1992; 1128: 44
- Kaplan H.M., Brewer N.R., Blair W.H. “The Mouse in Biomedical Research.”, H.L. Foster, J.D. Small, J.G. Fox. Academic Press, New York 1983; Vol.3: 248